At a glance
- Originator Aventis
- Class Antidepressants; Small molecules
- Mechanism of Action Adrenergic receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 14 Aug 1996 Discontinued-III for Depression in European Union (PO)